MINNEAPOLIS--(EON: Enhanced Online News)--Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has partnered with Cerner Corporation to develop a dynamic clinical documentation solution. The solution will leverage evidence-based ProVation® Clinic Note content and clinical decision support which, when embedded with Cerner Millennium®, will guide physician documentation and capture critical information at the point of care.
“This will allow physicians to improve the quality of care they are providing while maintaining the highest levels of productivity.”
This new agreement aims to create a state-of-the-art physician documentation solution. Specifically, as physicians review results, place orders and manage the problem list within Millennium, the solution will capture the necessary portions of documentation for the care being provided, with only relevant sections of the document rendering to physicians based on their role, the venue in which they are providing care, and the condition for which they are treating the patient.
“As physicians have transitioned from paper to the usage of Electronic Medical Records, the patient’s story has been lost. Our agreement with Wolters Kluwer Health will allow us to preserve the narrative while structuring key aspects of the note that then can be leveraged for clinical decision support to record and review more relevant information at the point of care,” said Brian Lancaster, Vice President, Physician Strategy, Cerner. “This will allow physicians to improve the quality of care they are providing while maintaining the highest levels of productivity.”
ProVation Clinic Note provides custom content specifically designed for EMR vendors. When embedded in an EMR system, it allows clinicians to quickly and easily create robust, evidence-based, structured physician documentation for patient encounters. Offering thousands of topics covering more than 30 specialties, ProVation Clinic Note delivers content across multiple patient settings, including ambulatory, inpatient and the emergency department.
“Cerner shares our vision of finding the most efficient and clinician-friendly ways to deliver the comprehensive information and intuitive tools physicians need to streamline clinical processes and improve overall quality and compliance,” said Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health, Clinical Solutions. “This dynamic documentation solution represents a convergence of two health IT industry leaders and the natural progression of our ProVation software from procedure documentation to advanced, intuitive clinical decision support that will drive safer, better and more cost-effective care.”
Wolters Kluwer Health will be exhibiting in Booth #417 at Cerner Health Conference in Kansas City, MO, Oct. 6-9, 2013.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.
About Cerner Corporation
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we’ve learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.
Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.
Certain trademarks, service marks and logos (collectively, the “Marks”) set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN. For more information about Cerner, please visit www.cerner.com, Twitter, Facebook and YouTube.
This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “aims” “will capture” and “will allow” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; risks related to our dependence on third party suppliers; government regulation; and, failure of the parties to achieve the intended benefits Additional discussion of these and other risks, uncertainties and factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.